NAPE-PLD Antibodies

Santa Cruz Biotechnology features a diverse variety of NAPE-PLD monoclonal antibodies for research focused on N-acyl phosphatidylethanolamine-specific phospholipase D (NAPE-PLD). NAPE-PLD Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).NAPE-PLD is a critical enzyme involved in the biosynthesis of bioactive lipids, particularly in the production of anandamide, an endocannabinoid that plays a significant role in regulating pain, mood, and appetite. Understanding NAPE-PLD function is essential for elucidating its involvement in various physiological processes and potential implications in neurodegenerative diseases and metabolic disorders. NAPE-PLD research can provide insights into therapeutic targets for modulating endocannabinoid signaling. Investigating NAPE-PLD expression patterns helps reveal its distribution across different tissues and cell types. Studying NAPE-PLD activity contributes to understanding lipid metabolism regulation. Examining NAPE-PLD interactions with other proteins unveils complex signaling networks.Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of lipid signaling pathways and their biological significance.